A 0 1 0 1 O
stress 2 8 2 8 B-treatment
cardiac 9 16 9 16 I-treatment
test 17 21 17 21 I-treatment
( 22 23 22 23 O
stress 23 29 23 29 B-treatment
thallium 30 38 30 38 I-treatment
, 38 39 38 39 O
stress 40 46 40 46 B-treatment
MUGA 47 51 47 51 I-treatment
, 51 52 51 52 O
dobutamine 53 63 53 63 B-treatment
echocardiogram 64 78 64 78 I-treatment
or 79 81 79 81 O
other 82 87 82 87 O
stress 88 94 88 94 O
test 95 99 95 99 O
that 100 104 100 104 O
will 105 109 105 109 O
rule 110 114 110 114 O
out 115 118 115 118 O
cardiac 119 126 119 126 B-chronic_disease
ischemia 127 135 127 135 I-chronic_disease
) 135 136 135 136 O
within 137 143 137 143 O
6 144 145 144 145 B-upper_bound
months 146 152 146 152 I-upper_bound
of 153 155 153 155 O
lymphodepletion 156 171 156 171 B-treatment
. 171 172 171 172 O
( 173 174 173 174 O
Turnstile 174 183 174 183 O
II 184 186 184 186 O
- 187 188 187 188 O
Chemotherapy 189 201 189 201 B-treatment
/ 201 202 201 202 I-treatment
Cell 202 206 202 206 I-treatment
Infusion 207 215 207 215 I-treatment
- 215 216 215 216 O
Inclusion 216 225 216 225 O
Criteria 226 234 226 234 O
) 234 235 234 235 O

Absolute 0 8 236 244 B-clinical_variable
neutrophil 9 19 245 255 I-clinical_variable
count 20 25 256 261 I-clinical_variable
greater 26 33 262 269 O
than 34 38 270 274 O
or 39 41 275 277 O
equal 42 47 278 283 O
to 48 50 284 286 O
750 51 54 287 290 B-lower_bound
/ 54 55 290 291 I-lower_bound
mm3 55 58 291 294 I-lower_bound
. 58 59 294 295 O
( 60 61 296 297 O
Turnstile 61 70 297 306 B-treatment
II 71 73 307 309 I-treatment
- 74 75 310 311 I-treatment
Chemotherapy 76 88 312 324 I-treatment
/ 88 89 324 325 I-treatment
Cell 89 93 325 329 I-treatment
Infusion- 94 103 330 339 I-treatment
Inclusion 104 113 340 349 O
Criteria 114 122 350 358 O
) 122 123 358 359 O

Achieves 0 8 360 368 O
PR 9 11 369 371 O
or 12 14 372 374 O
CR 15 17 375 377 O
in 18 20 378 380 O
response 21 29 381 389 O
to 30 32 390 392 O
B 33 34 393 394 B-treatment
- 34 35 394 395 I-treatment
RAF 35 38 395 398 I-treatment
treatment 39 48 399 408 I-treatment
( 49 50 409 410 O
Cohort 50 56 410 416 O
C 57 58 417 418 O
) 58 59 418 419 O

Age 0 3 420 423 B-gender
greater 4 11 424 431 O
than 12 16 432 436 O
or 17 19 437 439 O
equal 20 25 440 445 O
to 26 28 446 448 O
12 29 31 449 451 B-lower_bound
years 32 37 452 457 I-lower_bound
. 37 38 457 458 O
( 39 40 459 460 O
Turnstile 40 49 460 469 O
I 50 51 470 471 O
) 51 52 471 472 O

Any 0 3 473 476 O
active 4 10 477 483 B-chronic_disease
systemic 11 19 484 492 I-chronic_disease
infections 20 30 493 503 I-chronic_disease
requiring 31 40 504 513 O
intravenous 41 52 514 525 B-treatment
antibiotics 53 64 526 537 I-treatment
, 64 65 537 538 O
coagulation 66 77 539 550 B-chronic_disease
disorders 78 87 551 560 I-chronic_disease
or 88 90 561 563 O
other 91 96 564 569 O
major 97 102 570 575 O
medical 103 110 576 583 B-chronic_disease
illnesses 111 120 584 593 I-chronic_disease
of 121 123 594 596 O
the 124 127 597 600 O
cardiovascular 128 142 601 615 B-chronic_disease
, 142 143 615 616 O
respiratory 144 155 617 628 B-chronic_disease
or 156 158 629 631 O
immune 159 165 632 638 B-chronic_disease
system 166 172 639 645 I-chronic_disease
, 172 173 645 646 O
such 174 178 647 651 O
as 179 181 652 654 O
abnormal 182 190 655 663 B-clinical_variable
stress 191 197 664 670 I-clinical_variable
test 198 202 671 675 I-clinical_variable
and/or 203 209 676 682 O
abnormal 210 218 683 691 O
PFT 219 222 692 695 B-clinical_variable
. 222 223 695 696 O
PI 224 226 697 699 O
or 227 229 700 702 O
his 230 233 703 706 O
designee 234 242 707 715 O
shall 243 248 716 721 O
make 249 253 722 726 O
the 254 257 727 730 O
final 258 263 731 736 O
determination 264 277 737 750 O
regarding 278 287 751 760 O
appropriateness 288 303 761 776 O
of 304 306 777 779 O
enrollment.(Turnstile 307 328 780 801 O
II 329 331 802 804 O
- 332 333 805 806 O
Chemotherapy 334 346 807 819 B-treatment
/ 346 347 819 820 O
Cell 347 351 820 824 B-treatment
Infusion 352 360 825 833 I-treatment
Exclusion 361 370 834 843 O
Criteria 371 379 844 852 O
) 379 380 852 853 O

Any 0 3 854 857 O
form 4 8 858 862 O
of 9 11 863 865 O
primary 12 19 866 873 O
or 20 22 874 876 O
secondary 23 32 877 886 O
immunodeficiency 33 49 887 903 B-chronic_disease
. 49 50 903 904 O
Must 51 55 905 909 O
have 56 60 910 914 O
recovered 61 70 915 924 O
immune 71 77 925 931 O
competence 78 88 932 942 O
after 89 94 943 948 O
chemotherapy 95 107 949 961 B-treatment
or 108 110 962 964 O
radiation 111 120 965 974 B-treatment
therapy 121 128 975 982 I-treatment
as 129 131 983 985 O
evidenced 132 141 986 995 O
by 142 144 996 998 O
lymphocyte 145 155 999 1009 B-clinical_variable
counts 156 162 1010 1016 I-clinical_variable
( 163 164 1017 1018 O
> 164 165 1018 1019 O
500 166 169 1020 1023 B-lower_bound
/ 169 170 1023 1024 I-lower_bound
mm3 170 173 1024 1027 I-lower_bound
) 173 174 1027 1028 O
, 174 175 1028 1029 O
WBC 176 179 1030 1033 B-clinical_variable
( 180 181 1034 1035 O
> 181 182 1035 1036 O
3,000 183 188 1037 1042 B-lower_bound
/ 188 189 1042 1043 I-lower_bound
mm3 189 192 1043 1046 I-lower_bound
) 192 193 1046 1047 O
or 194 196 1048 1050 O
absence 197 204 1051 1058 O
of 205 207 1059 1061 O
opportunistic 208 221 1062 1075 B-chronic_disease
infections 222 232 1076 1086 I-chronic_disease
. 232 233 1086 1087 O
( 234 235 1088 1089 O
Turnstile 235 244 1089 1098 O
II 245 247 1099 1101 O
- 248 249 1102 1103 O
Chemotherapy 250 262 1104 1116 B-treatment
/ 262 263 1116 1117 O
Cell 263 267 1117 1121 B-treatment
Infusion 268 276 1122 1130 I-treatment
Exclusion 277 286 1131 1140 O
Criteria 287 295 1141 1149 O
) 295 296 1149 1150 O

Clinical 0 8 1151 1159 O
performance 9 20 1160 1171 O
status 21 27 1172 1178 O
of 28 30 1179 1181 O
ECOG 31 35 1182 1186 B-clinical_variable
0 36 37 1187 1188 B-lower_bound
- 38 39 1189 1190 O
2 40 41 1191 1192 B-upper_bound
at 42 44 1193 1195 O
the 45 48 1196 1199 O
time 49 53 1200 1204 O
of 54 56 1205 1207 O
chemotherapy 57 69 1208 1220 B-treatment
infusion 70 78 1221 1229 I-treatment
. 78 79 1229 1230 O
( 80 81 1231 1232 O
Turnstile 81 90 1232 1241 B-treatment
II 91 93 1242 1244 I-treatment
- 94 95 1245 1246 I-treatment
Chemotherapy 96 108 1247 1259 I-treatment
/ 108 109 1259 1260 I-treatment
Cell 109 113 1260 1264 I-treatment
Infusion 114 122 1265 1273 I-treatment
- 122 123 1273 1274 O
Inclusion 123 132 1274 1283 O
Criteria 133 141 1284 1292 O
) 141 142 1292 1293 O

Clinical 0 8 1294 1302 B-clinical_variable
performance 9 20 1303 1314 I-clinical_variable
status 21 27 1315 1321 I-clinical_variable
of 28 30 1322 1324 O
ECOG 31 35 1325 1329 B-clinical_variable
0 36 37 1330 1331 B-lower_bound
- 37 38 1331 1332 O
2 38 39 1332 1333 B-upper_bound
. 39 40 1333 1334 O
( 41 42 1335 1336 O
Turnstile 42 51 1336 1345 O
I 52 53 1346 1347 O
) 53 54 1347 1348 O

Has 0 3 1349 1352 O
had 4 7 1353 1356 O
prior 8 13 1357 1362 B-treatment
B 14 15 1363 1364 I-treatment
- 15 16 1364 1365 I-treatment
RAF 16 19 1365 1368 I-treatment
or 20 22 1369 1371 O
MEK 23 26 1372 1375 B-treatment
targeted 27 35 1376 1384 I-treatment
therapy 36 43 1385 1392 I-treatment
within 44 50 1393 1399 O
7 51 52 1400 1401 B-upper_bound
days 53 57 1402 1406 I-upper_bound
prior 58 63 1407 1412 I-upper_bound
to 64 66 1413 1415 O
the 67 70 1416 1419 O
start 71 76 1420 1425 O
of 77 79 1426 1428 O
the 80 83 1429 1432 O
lymphodepletion 84 99 1433 1448 B-treatment
regimen 100 107 1449 1456 I-treatment
( 108 109 1457 1458 O
Cohort 109 115 1458 1464 O
A 116 117 1465 1466 O
and 118 121 1467 1470 O
Cohort 122 128 1471 1477 O
B 129 130 1478 1479 O
) 130 131 1479 1480 O

Has 0 3 1481 1484 O
had 4 7 1485 1488 O
prior 8 13 1489 1494 B-treatment
systemic 14 22 1495 1503 I-treatment
cancer 23 29 1504 1510 I-treatment
cytotoxic 30 39 1511 1520 I-treatment
chemotherapy 40 52 1521 1533 I-treatment
within 53 59 1534 1540 O
the 60 63 1541 1544 O
past 64 68 1545 1549 B-upper_bound
four 69 73 1550 1554 I-upper_bound
weeks 74 79 1555 1560 I-upper_bound
at 80 82 1561 1563 O
the 83 86 1564 1567 O
time 87 91 1568 1572 O
of 92 94 1573 1575 O
the 95 98 1576 1579 O
start 99 104 1580 1585 O
of 105 107 1586 1588 O
the 108 111 1589 1592 O
lymphodepletion 112 127 1593 1608 B-treatment
regimen 128 135 1609 1616 O

Hemoglobin 0 10 1617 1627 B-clinical_variable
greater 11 18 1628 1635 O
than 19 23 1636 1640 O
or 24 26 1641 1643 O
equal 27 32 1644 1649 O
to 33 35 1650 1652 O
8.0 36 39 1653 1656 B-lower_bound
g 40 41 1657 1658 I-lower_bound
/ 41 42 1658 1659 I-lower_bound
dl 42 44 1659 1661 I-lower_bound
. 44 45 1661 1662 O
( 46 47 1663 1664 O
Turnstile 47 56 1664 1673 O
II 57 59 1674 1676 O
- 60 61 1677 1678 O
Chemotherapy 62 74 1679 1691 B-treatment
/ 74 75 1691 1692 O
Cell 75 79 1692 1696 B-treatment
Infusion 80 88 1697 1705 I-treatment
) 88 89 1705 1706 O

Is 0 2 1707 1709 O
not 3 6 1710 1713 O
receiving 7 16 1714 1723 O
B 17 18 1724 1725 B-treatment
- 18 19 1725 1726 I-treatment
RAF 19 22 1726 1729 I-treatment
treatment 23 32 1730 1739 I-treatment
( 33 34 1740 1741 O
Cohort 34 40 1741 1747 O
C 41 42 1748 1749 O
) 42 43 1749 1750 O
( 44 45 1751 1752 O
Turnstile 45 54 1752 1761 O
II 55 57 1762 1764 O
- 58 59 1765 1766 O
Chemotherapy 60 72 1767 1779 B-treatment
/ 72 73 1779 1780 O
Cell 73 77 1780 1784 B-treatment
Infusion 78 86 1785 1793 I-treatment
Exclusion 87 96 1794 1803 O
Criteria 97 105 1804 1812 O
) 105 106 1812 1813 O

MRI 0 3 1814 1817 B-treatment
/ 3 4 1817 1818 I-treatment
CT 4 6 1818 1820 I-treatment
of 7 9 1821 1823 I-treatment
the 10 13 1824 1827 I-treatment
brain 14 19 1828 1833 I-treatment
within 20 26 1834 1840 O
42 27 29 1841 1843 B-upper_bound
days 30 34 1844 1848 I-upper_bound
of 35 37 1849 1851 O
lymphodepletion 38 53 1852 1867 B-chronic_disease
. 53 54 1867 1868 O
CT 55 57 1869 1871 B-treatment
scan 58 62 1872 1876 I-treatment
of 63 65 1877 1879 I-treatment
chest 66 71 1880 1885 I-treatment
/ 71 72 1885 1886 I-treatment
abdomen 72 79 1886 1893 I-treatment
/ 79 80 1893 1894 I-treatment
pelvis 80 86 1894 1900 I-treatment
or 87 89 1901 1903 O
PET 90 93 1904 1907 B-treatment
/ 93 94 1907 1908 I-treatment
CT 94 96 1908 1910 I-treatment
within 97 103 1911 1917 O
30 104 106 1918 1920 B-upper_bound
days 107 111 1921 1925 I-upper_bound
of 112 114 1926 1928 O
lymphodepletion 115 130 1929 1944 O

Many 0 4 1945 1949 O
patients 5 13 1950 1958 O
present 14 21 1959 1966 O
with 22 26 1967 1971 O
concomitant 27 38 1972 1983 O
systemic 39 47 1984 1992 B-chronic_disease
disease 48 55 1993 2000 I-chronic_disease
outside 56 63 2001 2008 O
of 64 66 2009 2011 O
the 67 70 2012 2015 O
central 71 78 2016 2023 O
nervous 79 86 2024 2031 O
system 87 93 2032 2038 O

Patients 0 8 2039 2047 O
may 9 12 2048 2051 O
have 13 17 2052 2056 O
brain 18 23 2057 2062 B-chronic_disease
lesions 24 31 2063 2070 I-chronic_disease
which 32 37 2071 2076 O
measure 38 45 2077 2084 O
< 46 47 2085 2086 O
/= 47 49 2086 2088 O
1 50 51 2089 2090 B-upper_bound
cm 51 53 2090 2092 I-upper_bound
each 54 58 2093 2097 O
. 58 59 2097 2098 O
Lesions 60 67 2099 2106 O
that 68 72 2107 2111 O
are 73 76 2112 2115 O
> 77 78 2116 2117 O
1 78 79 2117 2118 B-lower_bound
cm 80 82 2119 2121 I-lower_bound
that 83 87 2122 2126 O
have 88 92 2127 2131 O
been 93 97 2132 2136 O
treated 98 105 2137 2144 O
with 106 110 2145 2149 O
SRS 111 114 2150 2153 B-treatment
and 115 118 2154 2157 O
in 119 121 2158 2160 O
the 122 125 2161 2164 O
opinion 126 133 2165 2172 O
of 134 136 2173 2175 O
the 137 140 2176 2179 O
PI 141 143 2180 2182 O
or 144 146 2183 2185 O
his 147 150 2186 2189 O
designee 151 159 2190 2198 O
no 160 162 2199 2201 O
longer 163 169 2202 2208 O
represents 170 180 2209 2219 O
active 181 187 2220 2226 O
disease 188 195 2227 2234 O
will 196 200 2235 2239 O
also 201 205 2240 2244 O
be 206 208 2245 2247 O
allowed 209 216 2248 2255 O
. 216 217 2255 2256 O
( 218 219 2257 2258 O
Turnstile 219 228 2258 2267 O
II 229 231 2268 2270 O
- 232 233 2271 2272 O
Chemotherapy 234 246 2273 2285 B-treatment
/ 246 247 2285 2286 O
Cell 247 251 2286 2290 B-treatment
Infusion- 252 261 2291 2300 I-treatment
Inclusion 262 271 2301 2310 O
Criteria 272 280 2311 2319 O
) 280 281 2319 2320 O

Patients 0 8 2321 2329 O
must 9 13 2330 2334 O
be 14 16 2335 2337 O
HLA 17 20 2338 2341 O
- 20 21 2341 2342 O
A2 21 23 2342 2344 O
for 24 27 2345 2348 O
cohort 28 34 2349 2355 O
A. 35 37 2356 2358 O
( 38 39 2359 2360 O
Turnstile 39 48 2360 2369 B-treatment
II 49 51 2370 2372 I-treatment
- 51 52 2372 2373 I-treatment
Chemotherapy 52 64 2373 2385 I-treatment
/ 64 65 2385 2386 O
Cell 65 69 2386 2390 B-treatment
Infusion 70 78 2391 2399 I-treatment
- 78 79 2399 2400 O
Inclusion 79 88 2400 2409 O
Criteria 89 97 2410 2418 O
) 97 98 2418 2419 O

Patients 0 8 2420 2428 O
must 9 13 2429 2433 O
be 14 16 2434 2436 O
able 17 21 2437 2441 O
to 22 24 2442 2444 O
undergo 25 32 2445 2452 O
contrast 33 41 2453 2461 B-treatment
- 41 42 2461 2462 I-treatment
enhanced 42 50 2462 2470 I-treatment
MRI 51 54 2471 2474 I-treatment
. 54 55 2474 2475 O
( 56 57 2476 2477 O
Cohort 57 63 2477 2483 O
D 64 65 2484 2485 O
) 65 66 2485 2486 O

Patients 0 8 2487 2495 O
must 9 13 2496 2500 O
be 14 16 2501 2503 O
receiving 17 26 2504 2513 O
a 27 28 2514 2515 O
B 29 30 2516 2517 B-treatment
- 30 31 2517 2518 I-treatment
RAF 31 34 2518 2521 I-treatment
inhibitor 35 44 2522 2531 I-treatment
and 45 48 2532 2535 O
failed 49 55 2536 2542 O
to 56 58 2543 2545 O
achieve 59 66 2546 2553 O
PR 67 69 2554 2556 O
or 70 72 2557 2559 O
CR 73 75 2560 2562 O
or 76 78 2563 2565 O
have 79 83 2566 2570 O
progressive 84 95 2571 2582 O
disease 96 103 2583 2590 O
in 104 106 2591 2593 O
response 107 115 2594 2602 O
to 116 118 2603 2605 O
B 119 120 2606 2607 B-treatment
- 120 121 2607 2608 I-treatment
RAF 121 124 2608 2611 I-treatment
treatment 125 134 2612 2621 I-treatment
( 135 136 2622 2623 O
Cohort 136 142 2623 2629 O
C 143 144 2630 2631 O
) 144 145 2631 2632 O

Patients 0 8 2633 2641 O
must 9 13 2642 2646 O
have 14 18 2647 2651 O
ECOG 19 23 2652 2656 B-clinical_variable
performance 24 35 2657 2668 I-clinical_variable
status 36 42 2669 2675 I-clinical_variable
0 43 44 2676 2677 B-lower_bound
, 44 45 2677 2678 O
1 46 47 2679 2680 O
or 48 50 2681 2683 O
2 51 52 2684 2685 B-upper_bound
and/or 53 59 2686 2692 O
KPS 60 63 2693 2696 B-clinical_variable
> 64 65 2697 2698 O
50 66 68 2699 2701 B-lower_bound

Patients 0 8 2702 2710 O
must 9 13 2711 2715 O
have 14 18 2716 2720 O
a 19 20 2721 2722 O
documented 21 31 2723 2733 O
negative 32 40 2734 2742 B-pregnancy
pregnancy 41 50 2743 2752 I-pregnancy
test 51 55 2753 2757 O
( 56 57 2758 2759 O
urine 57 62 2759 2764 O
or 63 65 2765 2767 O
serum 66 71 2768 2773 O
) 71 72 2773 2774 O
for 73 76 2775 2778 O
women 77 82 2779 2784 B-gender
who 83 86 2785 2788 O
have 87 91 2789 2793 O
menstruation 92 104 2794 2806 O
in 105 107 2807 2809 O
the 108 111 2810 2813 O
past 112 116 2814 2818 B-upper_bound
12 117 119 2819 2821 I-upper_bound
months 120 126 2822 2828 I-upper_bound
and 127 130 2829 2832 O
without 131 138 2833 2840 O
sterilization 139 152 2841 2854 B-treatment
surgery 153 160 2855 2862 I-treatment

Patients 0 8 2863 2871 O
must 9 13 2872 2876 O
have 14 18 2877 2881 O
measurable 19 29 2882 2892 O
metastatic 30 40 2893 2903 B-cancer
melanoma 41 49 2904 2912 I-cancer
. 49 50 2912 2913 O
( 51 52 2914 2915 O
Turnstile 52 61 2915 2924 O
II 62 64 2925 2927 O
- 65 66 2928 2929 O
Chemotherapy 67 79 2930 2942 B-treatment
/ 79 80 2942 2943 O
Cell 80 84 2943 2947 B-treatment
Infusion 85 93 2948 2956 I-treatment
-Inclusion 94 104 2957 2967 O
Criteria 105 113 2968 2976 O
) 113 114 2976 2977 O

Patients 0 8 2978 2986 O
must 9 13 2987 2991 O
have 14 18 2992 2996 O
metastatic 19 29 2997 3007 B-cancer
melanoma 30 38 3008 3016 I-cancer
, 38 39 3016 3017 O
uveal 40 45 3018 3023 B-cancer
melanoma 46 54 3024 3032 I-cancer
or 55 57 3033 3035 O
stage 58 63 3036 3041 B-cancer
III 64 67 3042 3045 I-cancer
in 68 70 3046 3048 I-cancer
- 70 71 3048 3049 I-cancer
transit 71 78 3049 3056 I-cancer
or 79 81 3057 3059 O
regional 82 90 3060 3068 B-chronic_disease
nodal 91 96 3069 3074 I-chronic_disease
disease 97 104 3075 3082 I-chronic_disease
. 104 105 3082 3083 O
( 106 107 3084 3085 O
Turnstile 107 116 3085 3094 O
I 117 118 3095 3096 O
) 118 119 3096 3097 O

Patients 0 8 3098 3106 O
must 9 13 3107 3111 O
receive 14 21 3112 3119 O
an 22 24 3120 3122 O
MRI 25 28 3123 3126 B-treatment
/ 28 29 3126 3127 I-treatment
CT 29 31 3127 3129 I-treatment
of 32 34 3130 3132 I-treatment
the 35 38 3133 3136 I-treatment
brain 39 44 3137 3142 I-treatment
or 45 47 3143 3145 O
PET 48 51 3146 3149 B-treatment
/ 51 52 3149 3150 I-treatment
CT 52 54 3150 3152 I-treatment
within 55 61 3153 3159 O
6 62 63 3160 3161 B-upper_bound
months 64 70 3162 3168 I-upper_bound
of 71 73 3169 3171 O
consenting 74 84 3172 3182 O
. 84 85 3182 3183 O
If 86 88 3184 3186 O
new 89 92 3187 3190 O
lesions 93 100 3191 3198 O
are 101 104 3199 3202 O
present 105 112 3203 3210 O
, 112 113 3210 3211 O
PI 114 116 3212 3214 O
or 117 119 3215 3217 O
his 120 123 3218 3221 O
designee 124 132 3222 3230 O
should 133 139 3231 3237 O
make 140 144 3238 3242 O
final 145 150 3243 3248 O
determination 151 164 3249 3262 O
regarding 165 174 3263 3272 O
enrollment 175 185 3273 3283 O
. 185 186 3283 3284 O
( 187 188 3285 3286 O
Turnstile 188 197 3286 3295 O
I 198 199 3296 3297 O
) 199 200 3297 3298 O

Patients 0 8 3299 3307 O
of 9 11 3308 3310 O
both 12 16 3311 3315 O
genders 17 24 3316 3323 O
must 25 29 3324 3328 O
practice 30 38 3329 3337 B-contraception_consent
birth 39 44 3338 3343 I-contraception_consent
control 45 52 3344 3351 I-contraception_consent
for 53 56 3352 3355 O
four 57 61 3356 3360 B-upper_bound
months 62 68 3361 3367 I-upper_bound
after 69 74 3368 3373 I-upper_bound
receiving 75 84 3374 3383 O
the 85 88 3384 3387 O
preparative 89 100 3388 3399 O
regimen 101 108 3400 3407 O
. 108 109 3407 3408 O
( 110 111 3409 3410 O
Turnstile 111 120 3410 3419 O
II 121 123 3420 3422 O
- 124 125 3423 3424 O
Chemotherapy 126 138 3425 3437 B-treatment
/ 138 139 3437 3438 O
Cell 139 143 3438 3442 B-treatment
Infusion- 144 153 3443 3452 I-treatment
Inclusion 154 163 3453 3462 O
Criteria 164 172 3463 3471 O
) 172 173 3471 3472 O

Patients 0 8 3473 3481 O
previously 9 19 3482 3492 O
treated 20 27 3493 3500 O
with 28 32 3501 3505 O
immunotherapy 33 46 3506 3519 B-treatment
, 46 47 3519 3520 O
targeted 48 56 3521 3529 B-treatment
therapy 57 64 3530 3537 I-treatment
, 64 65 3537 3538 O
or 66 68 3539 3541 O
no 69 71 3542 3544 O
therapy 72 79 3545 3552 O
will 80 84 3553 3557 O
be 85 87 3558 3560 O
eligible 88 96 3561 3569 O
. 96 97 3569 3570 O
Patients 98 106 3571 3579 O
receiving 107 116 3580 3589 O
cytotoxic 117 126 3590 3599 B-treatment
agents 127 133 3600 3606 I-treatment
will 134 138 3607 3611 O
be 139 141 3612 3614 O
evaluated 142 151 3615 3624 O
by 152 154 3625 3627 O
the 155 158 3628 3631 O
PI 159 161 3632 3634 O
or 162 164 3635 3637 O
his 165 168 3638 3641 O
designee 169 177 3642 3650 O
as 178 180 3651 3653 O
to 181 183 3654 3656 O
suitable 184 192 3657 3665 O
eligibility 193 204 3666 3677 O
. 204 205 3677 3678 O
( 206 207 3679 3680 O
Turnstile 207 216 3680 3689 O
I 217 218 3690 3691 O
) 218 219 3691 3692 O

Patients 0 8 3693 3701 O
randomized 9 19 3702 3712 O
to 20 22 3713 3715 O
receive 23 30 3716 3723 O
dendritic 31 40 3724 3733 O
cells 41 46 3734 3739 O
may 47 50 3740 3743 O
have 51 55 3744 3748 O
an 56 58 3749 3751 O
MRI 59 62 3752 3755 B-treatment
of 63 65 3756 3758 O
the 66 69 3759 3762 O
brain 70 75 3763 3768 O
within 76 82 3769 3775 O
30 83 85 3776 3778 B-upper_bound
days 86 90 3779 3783 I-upper_bound
of 91 93 3784 3786 O
lymphodepletion 94 109 3787 3802 B-treatment
. 109 110 3802 3803 O
( 111 112 3804 3805 O
Turnstile 112 121 3805 3814 O
II 122 124 3815 3817 O
- 124 125 3817 3818 O
Chemotherapy 125 137 3818 3830 B-treatment
/ 137 138 3830 3831 O
Cell 138 142 3831 3835 B-treatment
Infusion 143 151 3836 3844 I-treatment
- 151 152 3844 3845 O
Inclusion 152 161 3845 3854 O
Criteria 162 170 3855 3863 O
) 170 171 3863 3864 O

Patients 0 8 3865 3873 O
who 9 12 3874 3877 O
are 13 16 3878 3881 O
currently 17 26 3882 3891 O
being 27 32 3892 3897 O
treated 33 40 3898 3905 O
with 41 45 3906 3910 O
IT 46 48 3911 3913 B-treatment
IL-2 49 53 3914 3918 I-treatment
for 54 57 3919 3922 O
LMD 58 61 3923 3926 B-cancer
are 62 65 3927 3930 O
eligible 66 74 3931 3939 O
. 74 75 3939 3940 O
No 76 78 3941 3943 O
wash 79 83 3944 3948 O
out 84 87 3949 3952 O
period 88 94 3953 3959 O
is 95 97 3960 3962 O
required 98 106 3963 3971 O

Patients 0 8 3972 3980 O
who 9 12 3981 3984 O
have 13 17 3985 3989 O
been 18 22 3990 3994 O
previously 23 33 3995 4005 O
treated 34 41 4006 4013 O
with 42 46 4014 4018 O
other 47 52 4019 4024 O
IT 53 55 4025 4027 O
therapies 56 65 4028 4037 B-treatment
are 66 69 4038 4041 O
eligible 70 78 4042 4050 O
, 78 79 4050 4051 O
as 80 82 4052 4054 O
long 83 87 4055 4059 O
as 88 90 4060 4062 O
there 91 96 4063 4068 O
is 97 99 4069 4071 O
at 100 102 4072 4074 O
least 103 108 4075 4080 O
a 109 110 4081 4082 O
2 111 112 4083 4084 B-lower_bound
week 113 117 4085 4089 I-lower_bound
wash 118 122 4090 4094 O
out 123 126 4095 4098 O
period 127 133 4099 4105 O

Patients 0 8 4106 4114 O
who 9 12 4115 4118 O
have 13 17 4119 4123 O
previously 18 28 4124 4134 O
received 29 37 4135 4143 O
therapy 38 45 4144 4151 B-treatment
with 46 50 4152 4156 O
systemic 51 59 4157 4165 B-treatment
TIL 60 63 4166 4169 I-treatment
therapy 64 71 4170 4177 I-treatment
are 72 75 4178 4181 O
eligible 76 84 4182 4190 O

Patients 0 8 4191 4199 O
with 9 13 4200 4204 O
MRI 14 17 4205 4208 B-treatment
evidence 18 26 4209 4217 O
of 27 29 4218 4220 O
LMD 30 33 4221 4224 B-cancer
, 33 34 4224 4225 O
with 35 39 4226 4230 O
or 40 42 4231 4233 O
without 43 50 4234 4241 O
evidence 51 59 4242 4250 O
of 60 62 4251 4253 O
malignant 63 72 4254 4263 B-cancer
cells 73 78 4264 4269 I-cancer
in 79 81 4270 4272 I-cancer
CSF 82 85 4273 4276 I-cancer
( 86 87 4277 4278 O
positive 87 95 4278 4286 O
cytology 96 104 4287 4295 O
) 104 105 4295 4296 O

Patients 0 8 4297 4305 O
with 9 13 4306 4310 O
VP 14 16 4311 4313 B-treatment
shunts 17 23 4314 4320 I-treatment
must 24 28 4321 4325 O
have 29 33 4326 4330 O
VP 34 36 4331 4333 O
shunts 37 43 4334 4340 O
with 44 48 4341 4345 O
on 49 51 4346 4348 O
/ 51 52 4348 4349 O
off 52 55 4349 4352 O
valves 56 62 4353 4359 O
and 63 66 4360 4363 O
must 67 71 4364 4368 O
be 72 74 4369 4371 O
expected 75 83 4372 4380 O
to 84 86 4381 4383 O
tolerate 87 95 4384 4392 O
VP 96 98 4393 4395 B-treatment
shunt 99 104 4396 4401 I-treatment
valve 105 110 4402 4407 I-treatment
off 111 114 4408 4411 O
for 115 118 4412 4415 O
more 119 123 4416 4420 O
than 124 128 4421 4425 O
6 129 130 4426 4427 B-upper_bound
hours 131 136 4428 4433 I-upper_bound
Patients 137 145 4434 4442 O
who 146 149 4443 4446 O
have 150 154 4447 4451 O
received 155 163 4452 4460 O
CNS 164 167 4461 4464 B-treatment
irradiation 168 179 4465 4476 I-treatment
, 179 180 4476 4477 O
including 181 190 4478 4487 O
whole 191 196 4488 4493 B-treatment
brain 197 202 4494 4499 I-treatment
radiation 203 212 4500 4509 I-treatment
or 213 215 4510 4512 O
stereotactic 216 228 4513 4525 B-treatment
radiosurgery 229 241 4526 4538 I-treatment
, 241 242 4538 4539 O
are 243 246 4540 4543 O
eligible 247 255 4544 4552 O
, 255 256 4552 4553 O
if 257 259 4554 4556 O
they 260 264 4557 4561 O
are 265 268 4562 4565 O
at 269 271 4566 4568 O
least 272 277 4569 4574 O
1 278 279 4575 4576 B-lower_bound
weeks 280 285 4577 4582 I-lower_bound
post 286 290 4583 4587 O
CNS 291 294 4588 4591 B-treatment
- 294 295 4591 4592 I-treatment
irradiation 295 306 4592 4603 I-treatment
( 307 308 4604 4605 O
Cohort 308 314 4605 4611 O
D)Patients 315 325 4612 4622 O
who 326 329 4623 4626 O
are 330 333 4627 4630 O
currently 334 343 4631 4640 O
being 344 349 4641 4646 O
treated 350 357 4647 4654 O
with 358 362 4655 4659 O
IT 363 365 4660 4662 B-clinical_variable
IL-2 366 370 4663 4667 I-clinical_variable
for 371 374 4668 4671 O
LMD 375 378 4672 4675 B-cancer
are 379 382 4676 4679 O
eligible 383 391 4680 4688 O
. 391 392 4688 4689 O
No 393 395 4690 4692 O
wash 396 400 4693 4697 O
out 401 404 4698 4701 O
period 405 411 4702 4708 O
is 412 414 4709 4711 O
required 415 423 4712 4720 O
. 423 424 4720 4721 O
( 425 426 4722 4723 O
Cohort 426 432 4723 4729 O
D 433 434 4730 4731 O
) 434 435 4731 4732 O

Patients 0 8 4733 4741 O
with 9 13 4742 4746 O
concomitant 14 25 4747 4758 O
systemic 26 34 4759 4767 B-chronic_disease
disease 35 42 4768 4775 I-chronic_disease
under 43 48 4776 4781 O
control 49 56 4782 4789 O
with 57 61 4790 4794 O
current 62 69 4795 4802 O
or 70 72 4803 4805 O
prior 73 78 4806 4811 B-treatment
systemic 79 87 4812 4820 I-treatment
treatment 88 97 4821 4830 I-treatment
, 97 98 4830 4831 O
as 99 101 4832 4834 O
per 102 105 4835 4838 O
primary 106 113 4839 4846 O
treating 114 122 4847 4855 O
physician 123 132 4856 4865 O

Patients 0 8 4866 4874 O
with 9 13 4875 4879 O
evidence 14 22 4880 4888 O
of 23 25 4889 4891 O
malignant 26 35 4892 4901 B-cancer
cells 36 41 4902 4907 I-cancer
in 42 44 4908 4910 O
the 45 48 4911 4914 O
CSF 49 52 4915 4918 O
( 53 54 4919 4920 O
positive 54 62 4920 4928 O
cytology 63 71 4929 4937 O
) 71 72 4937 4938 O
, 72 73 4938 4939 O
with 74 78 4940 4944 O
or 79 81 4945 4947 O
without 82 89 4948 4955 O
MRI 90 93 4956 4959 B-treatment
evidence 94 102 4960 4968 O
of 103 105 4969 4971 O
LMD 106 109 4972 4975 O

Patients 0 8 4976 4984 O
with 9 13 4985 4989 O
rapidly 14 21 4990 4997 O
advancing 22 31 4998 5007 O
parenchymal 32 43 5008 5019 O
brain 44 49 5020 5025 B-cancer
metastases 50 60 5026 5036 I-cancer
( 61 62 5037 5038 O
Cohort 62 68 5038 5044 O
D 69 70 5045 5046 O
) 70 71 5046 5047 O

Patients 0 8 5048 5056 O
with 9 13 5057 5061 O
rapidly 14 21 5062 5069 O
advancing 22 31 5070 5079 O
systemic 32 40 5080 5088 B-chronic_disease
disease 41 48 5089 5096 I-chronic_disease
, 48 49 5096 5097 O
especially 50 60 5098 5108 O
those 61 66 5109 5114 O
without 67 74 5115 5122 O
good 75 79 5123 5127 O
options 80 87 5128 5135 O
of 88 90 5136 5138 O
systemic 91 99 5139 5147 B-treatment
treatment 100 109 5148 5157 I-treatment
for 110 113 5158 5161 O
their 114 119 5162 5167 O
disease 120 127 5168 5175 O
outside 128 135 5176 5183 O
the 136 139 5184 5187 O
CNS 140 143 5188 5191 O
. 143 144 5191 5192 O
( 145 146 5193 5194 O
Cohort 146 152 5194 5200 O
D 153 154 5201 5202 O
) 154 155 5202 5203 O

Patients 0 8 5204 5212 O
with 9 13 5213 5217 O
surgically 14 24 5218 5228 O
- 24 25 5228 5229 O
proven 25 31 5229 5235 O
LMD 32 35 5236 5239 B-cancer
( 36 37 5240 5241 O
leptomeningeal 37 51 5241 5255 O
involvement 52 63 5256 5267 O
on 64 66 5268 5270 O
pathology 67 76 5271 5280 O
review 77 83 5281 5287 O
) 83 84 5287 5288 O
+ 85 86 5289 5290 O
/- 86 88 5290 5292 O
MRI 89 92 5293 5296 B-treatment
or 93 95 5297 5299 O
CSF 96 99 5300 5303 O
evidence 100 108 5304 5312 O
by 109 111 5313 5315 O
MRI 112 115 5316 5319 O
or 116 118 5320 5322 O
CSF 119 122 5323 5326 O
cytology 123 131 5327 5335 O
( 132 133 5336 5337 O
Cohort 133 139 5337 5343 O
D 140 141 5344 5345 O
) 141 142 5345 5346 O

Patients 0 8 5347 5355 O
without 9 16 5356 5363 O
any 17 20 5364 5367 O
evidence 21 29 5368 5376 O
of 30 32 5377 5379 O
systemic 33 41 5380 5388 B-chronic_disease
disease 42 49 5389 5396 I-chronic_disease
, 49 50 5396 5397 O
either 51 57 5398 5404 O
receiving 58 67 5405 5414 O
systemic 68 76 5415 5423 B-treatment
treatment 77 86 5424 5433 I-treatment
or 87 89 5434 5436 O
on 90 92 5437 5439 O
active 93 99 5440 5446 O
observation 100 111 5447 5458 O
( 112 113 5459 5460 O
Cohort 113 119 5460 5466 O
D 120 121 5467 5468 O
) 121 122 5468 5469 O

Platelet 0 8 5470 5478 B-clinical_variable
count 9 14 5479 5484 I-clinical_variable
greater 15 22 5485 5492 O
than 23 27 5493 5497 O
or 28 30 5498 5500 O
equal 31 36 5501 5506 O
to 37 39 5507 5509 O
75,000 40 46 5510 5516 B-lower_bound
/ 46 47 5516 5517 I-lower_bound
mm3 47 50 5517 5520 I-lower_bound
. 50 51 5520 5521 O
( 52 53 5522 5523 O
Turnstile 53 62 5523 5532 O
II 63 65 5533 5535 O
- 66 67 5536 5537 O
Chemotherapy 68 80 5538 5550 B-treatment
/ 80 81 5550 5551 O
Cell 81 85 5551 5555 B-treatment
Infusion- 86 95 5556 5565 I-treatment
Inclusion 96 105 5566 5575 O
Criteria 106 114 5576 5584 O
) 114 115 5584 5585 O

Pregnancy 0 9 5586 5595 B-pregnancy
testing 10 17 5596 5603 O
will 18 22 5604 5608 O
be 23 25 5609 5611 O
performed 26 35 5612 5621 O
within 36 42 5622 5628 O
7 43 44 5629 5630 B-upper_bound
days 45 49 5631 5635 I-upper_bound
prior 50 55 5636 5641 I-upper_bound
to 56 58 5642 5644 O
treatment 59 68 5645 5654 B-treatment
. 68 69 5654 5655 O
( 70 71 5656 5657 O
Turnstile 71 80 5657 5666 O
II 81 83 5667 5669 O
) 83 84 5669 5670 O

Pregnant 0 8 5671 5679 B-pregnancy
patients 9 17 5680 5688 O
( 18 19 5689 5690 O
Cohort 19 25 5690 5696 O
D 26 27 5697 5698 O
) 27 28 5698 5699 O

Presence 0 8 5700 5708 O
of 9 11 5709 5711 O
a 12 13 5712 5713 O
significant 14 25 5714 5725 O
psychiatric 26 37 5726 5737 B-chronic_disease
disease 38 45 5738 5745 I-chronic_disease
, 45 46 5745 5746 O
which 47 52 5747 5752 O
in 53 55 5753 5755 O
the 56 59 5756 5759 O
opinion 60 67 5760 5767 O
of 68 70 5768 5770 O
the 71 74 5771 5774 O
principal 75 84 5775 5784 O
investigator 85 97 5785 5797 O
or 98 100 5798 5800 O
his 101 104 5801 5804 O
designee 105 113 5805 5813 O
, 113 114 5813 5814 O
would 115 120 5815 5820 O
prevent 121 128 5821 5828 O
adequate 129 137 5829 5837 O
informed 138 146 5838 5846 O
consent 147 154 5847 5854 O
or 155 157 5855 5857 O
render 158 164 5858 5864 O
immunotherapy 165 178 5865 5878 B-treatment
unsafe 179 185 5879 5885 O
or 186 188 5886 5888 O
contraindicated 189 204 5889 5904 O
. 204 205 5904 5905 O
( 206 207 5906 5907 O
Turnstile 207 216 5907 5916 O
II 217 219 5917 5919 O
- 220 221 5920 5921 O
Chemotherapy 222 234 5922 5934 B-treatment
/ 234 235 5934 5935 O
Cell 235 239 5935 5939 B-treatment
Infusion 240 248 5940 5948 I-treatment
Exclusion 249 258 5949 5958 O
Criteria 259 267 5959 5967 O
) 267 268 5967 5968 O

Pulmonary 0 9 5969 5978 B-clinical_variable
function 10 18 5979 5987 I-clinical_variable
tests 19 24 5988 5993 I-clinical_variable
( 25 26 5994 5995 O
FEV1>65 26 33 5995 6002 B-clinical_variable
% 33 34 6002 6003 I-lower_bound
or 35 37 6004 6006 O
FVC>65%of 38 47 6007 6016 B-clinical_variable
predicted 48 57 6017 6026 O
) 57 58 6026 6027 O
within 59 65 6028 6034 O
6 66 67 6035 6036 B-upper_bound
months 68 74 6037 6043 I-upper_bound
of 75 77 6044 6046 O
lymphodepletion 78 93 6047 6062 B-treatment
. 93 94 6062 6063 O
( 95 96 6064 6065 O
Turnstile 96 105 6065 6074 O
II 106 108 6075 6077 O
- 109 110 6078 6079 O
Chemotherapy 111 123 6080 6092 B-treatment
/ 123 124 6092 6093 O
Cell 124 128 6093 6097 B-treatment
Infusion 129 137 6098 6106 I-treatment
- 138 139 6107 6108 O
Inclusion 140 149 6109 6118 O
Criteria 150 158 6119 6127 O
) 158 159 6127 6128 O

Require 0 7 6129 6136 O
steroid 8 15 6137 6144 B-treatment
therapy 16 23 6145 6152 I-treatment
or 24 26 6153 6155 I-treatment
steroid 27 34 6156 6163 I-treatment
- 34 35 6163 6164 I-treatment
containing 35 45 6164 6174 I-treatment
compounds 46 55 6175 6184 I-treatment
, 55 56 6184 6185 O
or 57 59 6186 6188 O
have 60 64 6189 6193 O
used 65 69 6194 6198 O
systemic 70 78 6199 6207 B-treatment
steroids 79 87 6208 6216 I-treatment
in 88 90 6217 6219 O
the 91 94 6220 6223 O
past 95 99 6224 6228 B-upper_bound
30 100 102 6229 6231 I-upper_bound
days 103 107 6232 6236 I-upper_bound
, 107 108 6236 6237 O
or 109 111 6238 6240 O
have 112 116 6241 6245 O
used 117 121 6246 6250 O
topical 122 129 6251 6258 B-treatment
or 130 132 6259 6261 I-treatment
inhalational 133 145 6262 6274 I-treatment
steroids 146 154 6275 6283 I-treatment
in 155 157 6284 6286 O
the 158 161 6287 6290 O
past 162 166 6291 6295 B-upper_bound
2 167 168 6296 6297 I-upper_bound
weeks 169 174 6298 6303 I-upper_bound
prior 175 180 6304 6309 B-treatment
to 181 183 6310 6312 I-treatment
lymphodepletion 184 199 6313 6328 I-treatment
. 199 200 6328 6329 O
Exception 201 210 6330 6339 O
: 210 211 6339 6340 O
Patients 212 220 6341 6349 O
on 221 223 6350 6352 O
physiologic 224 235 6353 6364 O
dose 236 240 6365 6369 O
of 241 243 6370 6372 O
steroid 244 251 6373 6380 O
( 252 253 6381 6382 O
Turnstile 253 262 6382 6391 O
II 263 265 6392 6394 O
- 266 267 6395 6396 O
Chemotherapy 268 280 6397 6409 B-treatment
/ 280 281 6409 6410 O
Cell 281 285 6410 6414 B-treatment
Infusion 286 294 6415 6423 I-treatment
Exclusion 295 304 6424 6433 O
Criteria 305 313 6434 6442 O
) 313 314 6442 6443 O

Serum 0 5 6444 6449 B-clinical_variable
ALT 6 9 6450 6453 I-clinical_variable
less 10 14 6454 6458 O
than 15 19 6459 6463 O
three 20 25 6464 6469 B-upper_bound
times 26 31 6470 6475 I-upper_bound
the 32 35 6476 6479 I-upper_bound
upper 36 41 6480 6485 I-upper_bound
limit 42 47 6486 6491 I-upper_bound
of 48 50 6492 6494 I-upper_bound
normal 51 57 6495 6501 I-upper_bound
. 57 58 6501 6502 O
( 59 60 6503 6504 O
Turnstile 60 69 6504 6513 O
II 70 72 6514 6516 O
- 73 74 6517 6518 O
Chemotherapy 75 87 6519 6531 B-treatment
/ 87 88 6531 6532 O
Cell 88 92 6532 6536 B-treatment
Infusion- 93 102 6537 6546 I-treatment
Inclusion 103 112 6547 6556 O
Criteria 113 121 6557 6565 O
) 121 122 6565 6566 O

Serum 0 5 6567 6572 B-clinical_variable
creatinine 6 16 6573 6583 I-clinical_variable
less 17 21 6584 6588 O
than 22 26 6589 6593 O
or 27 29 6594 6596 O
equal 30 35 6597 6602 O
to 36 38 6603 6605 O
1.6 39 42 6606 6609 B-upper_bound
mg 43 45 6610 6612 I-upper_bound
/ 45 46 6612 6613 I-upper_bound
dl 46 48 6613 6615 I-upper_bound
. 48 49 6615 6616 O
( 50 51 6617 6618 O
Turnstile 51 60 6618 6627 O
II 61 63 6628 6630 O
- 64 65 6631 6632 O
Chemotherapy 66 78 6633 6645 B-treatment
/ 78 79 6645 6646 O
Cell 79 83 6646 6650 B-treatment
Infusion 84 92 6651 6659 I-treatment
- 92 93 6659 6660 O
Inclusion 93 102 6660 6669 O
Criteria 103 111 6670 6678 O
) 111 112 6678 6679 O

Total 0 5 6680 6685 B-clinical_variable
bilirubin 6 15 6686 6695 I-clinical_variable
less 16 20 6696 6700 O
than 21 25 6701 6705 O
or 26 28 6706 6708 O
equal 29 34 6709 6714 O
to 35 37 6715 6717 O
2.0 38 41 6718 6721 B-upper_bound
mg 42 44 6722 6724 I-upper_bound
/ 44 45 6724 6725 I-upper_bound
dl 45 47 6725 6727 I-upper_bound
, 47 48 6727 6728 O
except 49 55 6729 6735 O
in 56 58 6736 6738 O
patients 59 67 6739 6747 O
with 68 72 6748 6752 O
Gilbert 73 80 6753 6760 B-chronic_disease
's 80 82 6760 6762 I-chronic_disease
Syndrome 83 91 6763 6771 I-chronic_disease
who 92 95 6772 6775 O
must 96 100 6776 6780 O
have 101 105 6781 6785 O
a 106 107 6786 6787 O
total 108 113 6788 6793 B-clinical_variable
bilirubin 114 123 6794 6803 I-clinical_variable
less 124 128 6804 6808 O
than 129 133 6809 6813 O
3.0 134 137 6814 6817 B-upper_bound
mg 138 140 6818 6820 I-upper_bound
/ 140 141 6820 6821 I-upper_bound
dl 141 143 6821 6823 I-upper_bound
. 143 144 6823 6824 O
( 145 146 6825 6826 O
Turnstile 146 155 6826 6835 O
II 156 158 6836 6838 O
- 159 160 6839 6840 O
Chemotherapy 161 173 6841 6853 B-treatment
/ 173 174 6853 6854 O
Cell 174 178 6854 6858 B-treatment
Infusion 179 187 6859 6867 I-treatment
- 188 189 6868 6869 O
Inclusion 190 199 6870 6879 O
Criteria 200 208 6880 6888 O
) 208 209 6888 6889 O

Unless 0 6 6890 6896 O
surgically 7 17 6897 6907 O
sterile 18 25 6908 6915 O
by 26 28 6916 6918 O
bilateral 29 38 6919 6928 O
tubal 39 44 6929 6934 O
ligation 45 53 6935 6943 O
or 54 56 6944 6946 O
vasectomy 57 66 6947 6956 O
of 67 69 6957 6959 O
partner(s 70 79 6960 6969 O
) 79 80 6969 6970 O
, 80 81 6970 6971 O
the 82 85 6972 6975 O
patient 86 93 6976 6983 O
agrees 94 100 6984 6990 B-contraception_consent
to 101 103 6991 6993 I-contraception_consent
continue 104 112 6994 7002 I-contraception_consent
to 113 115 7003 7005 I-contraception_consent
use 116 119 7006 7009 I-contraception_consent
a 120 121 7010 7011 I-contraception_consent
barrier 122 129 7012 7019 I-contraception_consent
method 130 136 7020 7026 I-contraception_consent
of 137 139 7027 7029 I-contraception_consent
contraception 140 153 7030 7043 I-contraception_consent
throughout 154 164 7044 7054 O
the 165 168 7055 7058 O
study 169 174 7059 7064 O
such 175 179 7065 7069 O
as 180 182 7070 7072 O
: 182 183 7072 7073 O
condom 184 190 7074 7080 B-contraception_consent
, 190 191 7080 7081 O
diaphragm 192 201 7082 7091 B-contraception_consent
, 201 202 7091 7092 O
hormonal 203 211 7093 7101 B-contraception_consent
, 211 212 7101 7102 O
IUD 213 216 7103 7106 B-contraception_consent
, 216 217 7106 7107 O
or 218 220 7108 7110 O
sponge 221 227 7111 7117 B-contraception_consent
plus 228 232 7118 7122 I-contraception_consent
spermicide 233 243 7123 7133 I-contraception_consent
. 243 244 7133 7134 O
Abstinence 245 255 7135 7145 O
is 256 258 7146 7148 O
an 259 261 7149 7151 O
acceptable 262 272 7152 7162 O
form 273 277 7163 7167 O
of 278 280 7168 7170 O
birth 281 286 7171 7176 O
control 287 294 7177 7184 O
. 294 295 7184 7185 O
( 296 297 7186 7187 O
Turnstile 297 306 7187 7196 O
II 307 309 7197 7199 O
) 309 310 7199 7200 O

Women 0 5 7201 7206 B-gender

pregnant 0 8 7207 7215 B-pregnancy

will 0 4 7216 7220 O
be 5 7 7221 7223 O
excluded 8 16 7224 7232 O
because 17 24 7233 7240 O
of 25 27 7241 7243 O
the 28 31 7244 7247 O
potentially 32 43 7248 7259 O
dangerous 44 53 7260 7269 O
effects 54 61 7270 7277 O
of 62 64 7278 7280 O
the 65 68 7281 7284 O
preparative 69 80 7285 7296 O
chemotherapy 81 93 7297 7309 B-treatment
on 94 96 7310 7312 O
the 97 100 7313 7316 O
fetus 101 106 7317 7322 O
. 106 107 7322 7323 O
( 108 109 7324 7325 O
Turnstile 109 118 7325 7334 O
II 119 121 7335 7337 O
- 122 123 7338 7339 O
Chemotherapy 124 136 7340 7352 B-treatment
/ 136 137 7352 7353 O
Cell 137 141 7353 7357 B-treatment
Infusion 142 150 7358 7366 I-treatment
Exclusion 151 160 7367 7376 O
Criteria 161 169 7377 7385 O
) 169 170 7385 7386 O

